Implications in pharmaceutical practice by using nanomedicines
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Presentation
- By: STEMER, Gunar (Vienna General Hospital - Medical University, Austria)
Pharmacists are key stakeholders when it comes to selecting and evaluating drugs for inclusion in healthcare institutions’ formularies. Nanomedicines are diverse and heterogeneous products with a higher level of complexity regarding their assessment and evaluation. A profound knowledge of important characteristics is therefore necessary for all.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.